Jason Loveridge

Dr Jason Loveridge has been working in the biomedical technology industry for over 20 years and has extensive experience in developing clinical stage biotechnology companies. As a venture investor with JAFCO Nomura, Dr Loveridge participated and invested in the start-up of over 24 companies in Europe, the United States and Israel. Since 2005, he has been directly involved in the senior management of a number of small innovative companies in the biomedical field, specifically in refinancing and product commercialisation.
Bio last updated 16 Feb 2019

Article Timeline

Positions - Previous

PositionCompanyYearCompany's current rankWA staff
Non-Executive Director (Interim Chair 2016-2017)
Actinogen Medical
Actinogen Medical
2014 - 2018
Non-Executive Director
Resonance Health
Resonance Health
2013 - 2017117

Total Shareholder Return as at 31/01/19

1 year TSR5 year TSR
12thResonance Health262%1%
305thTransaction Solutions International-9%7%
726 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar


117th↓Resonance Health$2.9m
128th↑Transaction Solutions International$2.3m
229 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer